Yayınlar & Eserler

Yayın Ağı
Makaleler 19
Tümü (19)
SCI-E, SSCI, AHCI (15)
SCI-E, SSCI, AHCI, ESCI (17)
ESCI (2)
Scopus (19)
TRDizin (4)

1. Psoas and pectoralis muscle indices and brown adipose tissue activity may be prognostic indicators in older patients with multiple myeloma

Yilmaz Kars M., Kars T. U., Cayci M., Bagci M., Cirik S., Gunay A., et al.
International Journal of Hematology , cilt.124, sa.2, ss.215-227, 2026 (SCI-Expanded, Scopus)

2. Real-World Outcomes of Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia

Odabasi Giden A., Özatlı D., ERKURT M. A., Karakus A., SİNCAN G., HİNDİLERDEN F., et al.
Hemato , cilt.7, sa.2, 2026 (ESCI, Scopus)

3. Evaluation of patients diagnosed with follicular lymphoma: A multicenter study Foliküler Lenfoma Tanılı Hastaların Değerlendirilmesi: Çok Merkezli Çalışma

Kars T. U., Tekinalp A., Yaşkiran O., Alkiş N., Serenli Yeğen Z., Çiftciler R., et al.
Genel Tip Dergisi , cilt.36, sa.2026, 2026 (Scopus, TRDizin)

4. Therapeutic potential of Aronia melanocarpa in the prevention of bleomycin-induced lung fibrosis in rats

Bağcı M., Kars T. U., Kozan H. İ., YILMAZ S., UÇAR S., OKAN OFLAMAZ A., et al.
Eurasian Journal of Medicine and Oncology , cilt.9, sa.4, ss.248-257, 2025 (ESCI, Scopus)

5. Fresh and cryopreserved stem cell transplantation in myeloma patients: Does it make a difference on transplant outcomes?

ERKURT M. A., YILMAZ S., NAMDAROĞLU S., Demircioglu S., SARICI A., Cirik S., et al.
Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded, Scopus)

6. The role of heparin in autologous stem cell mobilization in patients with multiple myeloma

SARICI A., ERKURT M. A., YILMAZ S., Demircioglu S., BERBER İ., BAŞTÜRK A., et al.
Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded, Scopus)

7. The comparison of cyclophosphamide at different dose levels for stem cell mobilization in multiple myeloma

Karakus A., Hatipoglu U., Katircilar Y., ERKURT M. A., YILMAZ S., Cagliyan G. A., et al.
Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded, Scopus)

8. The effect of threosulfan-based versus busulfan-based preparation regimens on transplant outcomes

Aslan Candir B., Okumus N., Hindilerden I. Y., ERKURT M. A., NAMDAROĞLU S., Merter M., et al.
Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded, Scopus)

9. Is there a relationship between stem cell yield obtained from healthy donors and healthy donors’ blood type?

Katircilar Y., Sahin A., Aydin M. S., Erer K., ERKURT M. A., NAMDAROĞLU S., et al.
Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded, Scopus)

10. Does body mass index affect stem cell yield in healthy donors?

YILMAZ S., Okumus N., Seyhan M., Sahin R., Korkmaz G., ERKURT M. A., et al.
Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded, Scopus)

11. Does Wilms Tumour-1 Gene Mutation Affect Treatment Options and Response in Acute Myeloid Leukaemia?

YILMAZ S., Zorlu T., Cırık S., Hidayet E., Durdu A., Okumuş N., et al.
Acta Haematologica Oncologica Turcica , cilt.58, sa.1, ss.16-20, 2025 (Scopus, TRDizin)

12. What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?

Ulas T., NAMDAROĞLU S., Hindilerden I. Y., ERKURT M. A., Erer K., YİĞENOĞLU T. N., et al.
Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded, Scopus)

13. Are mesenchymal stem cells still effective in acute GvHD management?

Ulu B. U., Hindilerden I. Y., YİĞENOĞLU T. N., Tiryaki T. O., ERKURT M. A., Korkmaz G., et al.
Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded, Scopus)

14. The role of ruxolitinib in the management of acute GVHD

NAMDAROĞLU S., Hidayet E., Aydin M. S., ERKURT M. A., BERBER İ., Cinar O. E., et al.
Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded, Scopus)

15. Is there a relationship between vitamin D levels and graft versus host disease?

YİĞENOĞLU T. N., Ulu B. U., NAMDAROĞLU S., ERKURT M. A., Sahin R., Okumus N., et al.
Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded, Scopus)

16. Survey of Red Cell Transfusion Therapy and Immunohematology Services for Patients with Hemoglobinopathies in Türkiye Türkiye’de Hemoglobinopati Hastalarında Eritrosit Transfüzyon Tedavisi ve İmmünohematoloji Hizmetleri Araştırması

GÜRLEK GÖKÇEBAY D., ANDIÇ N., Flege W. A., Aygüneş U., Eker İ., GÜRSEL O., et al.
Turkish Journal of Hematology , cilt.42, sa.3, ss.196-202, 2025 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

17. Can Pseudothrombocytopenia be recognised at first look?

YILMAZ S., Daǧ M., KIZILARSLANOĞLU M. C., BAŞTÜRK A.
Medicine (United States) , cilt.102, sa.41, 2023 (SCI-Expanded, Scopus)

18. Long-term Results of Imatinib Discontinuation in Patients with Chronic-phase Chronic Myeloid Leukemia: A National Multicenter Prospective Study Kronik Faz Kronik Myeloid Lösemi Hastalarında İmatinib Tedavisinin Kesilmesinin Uzun Dönem Sonuçları: Ulusal Çok Merkezli Prospektif Bir Çalışma

SAVAŞ E. M., YILMAZ S., Dikyar A. A. B., ÖZKURT Z. N., ÖÇAL R., Can F., et al.
Turkish Journal of Hematology , cilt.40, sa.4, ss.236-241, 2023 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

19. Major depressive disorder is an independent predictor of the electrocardiographic frontal QRS-T angle and TP-TE/QT ratio

Yilmaz M., YILMAZ S.
Bratislava Medical Journal , cilt.124, sa.4, ss.313-319, 2023 (SCI-Expanded, Scopus) Creative Commons License
Metrikler

Yayın

19

Yayın (WoS)

17

Yayın (Scopus)

19

H-İndeks (WoS)

2

Atıf (Scopus)

20

H-İndeks (Scopus)

2

Tez Danışmanlığı

4

Açık Erişim

6